CAH vs. COR, MCK, STE, ZBH, PHG, BNTX, WST, ICLR, WAT, and ARGX
Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include Cencora (COR), McKesson (MCK), STERIS (STE), Zimmer Biomet (ZBH), Koninklijke Philips (PHG), BioNTech (BNTX), West Pharmaceutical Services (WST), ICON Public (ICLR), Waters (WAT), and argenx (ARGX). These companies are all part of the "medical" sector.
Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.
Cardinal Health presently has a consensus target price of $107.57, indicating a potential upside of 8.57%. Cencora has a consensus target price of $233.90, indicating a potential upside of 5.30%. Given Cardinal Health's higher possible upside, equities analysts plainly believe Cardinal Health is more favorable than Cencora.
Cardinal Health pays an annual dividend of $2.00 per share and has a dividend yield of 2.0%. Cencora pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cardinal Health pays out 88.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora pays out 22.3% of its earnings in the form of a dividend.
In the previous week, Cardinal Health had 11 more articles in the media than Cencora. MarketBeat recorded 13 mentions for Cardinal Health and 2 mentions for Cencora. Cardinal Health's average media sentiment score of 0.61 beat Cencora's score of 0.50 indicating that Cardinal Health is being referred to more favorably in the media.
Cencora has a net margin of 0.67% compared to Cardinal Health's net margin of 0.25%. Cencora's return on equity of 268.67% beat Cardinal Health's return on equity.
87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.2% of Cardinal Health shares are held by insiders. Comparatively, 15.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Cardinal Health received 165 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 71.66% of users gave Cardinal Health an outperform vote while only 65.12% of users gave Cencora an outperform vote.
Cardinal Health has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.47, indicating that its share price is 53% less volatile than the S&P 500.
Cencora has higher revenue and earnings than Cardinal Health. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Summary
Cencora beats Cardinal Health on 11 of the 19 factors compared between the two stocks.
Get Cardinal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardinal Health Competitors List
Related Companies and Tools
